ACROMEGALY CAUSED BY HYPOPHYSIS MICROADENOMA WITH DEVELOPMENT OF TYPE 2 DIABETES MELLITUS: CASE REPORT

ACROMEGALY CAUSED BY HYPOPHYSIS MICROADENOMA WITH DEVELOPMENT OF TYPE 2 DIABETES MELLITUS: CASE REPORT

Blog Article

Summary.In the described clinical case, the patient demonstrated that he suffer from the acromegaly since 1995.Due to MRI results revealed microadenoma pituitary.The patient held treating by dopamine receptor agonist, bromocriptine drug at a dose of 0.75-0.

5 mg per day.Under the influence of growth hormone treatment rates decreased from 29.0 ng/mL (1.15.96) to 5.

9 ng/mL.(10/25/ 15), the reference rate up to 3.0 ng/mL.Related and appeared as a complication of such endocrine diseases: in Condoms 2003, he was diagnosed with type 2 diabetes and nodular goiter.Diabetes is treated with oral antidiabetic drugs: metformin and gliclazide.

Diabetes is compensated.Indicators of AEG KDK911423M SOUS VIDE INTEGRATED VACUUM SEALING DRAWER BLACK GLASS/STAINLESS thyroid function within the normal values.Clinical features of the described case is that acromegaly beginning to manifest articular syndrome and only on its background began to emerge the typical patient acromegaly changes appearance.Also, clinical feature is the fact that the breach of diabetes in a patient came in 8 years from the beginning of the manifestation of acromegaly, although usually impaired glucose tolerance and acromegaly are usually diagnosed at the same time.Perhaps such a stitched development disorders of carbohydrate metabolism caused by the medicine of dopamine receptor agonist and thus decreased contra insulin action of growth hormone.